View Author
patient myeloma therapy lenalidomide dexamethasone study thalidomide treatment blood response factor survival university trial cancer serum bortezomib len /dex combination group table disease hospital department high-dose signi phase leukemia chain transplantation signi ficantly regimen chemotherapy light hematology randomized result month ef ficacy cell transplantation celgene high-dose therapy myeloma patients prophylaxi reduction autologou melphalan induction level outcome marrow venous thromboembolism cycle event doxorubicin cyclophosphamide agent recommendation progression prednisone j clin oncol stage institute analysis center incidence risk factors urine palumbo venou oncol dimopoulo 50 years high-dose dexamethasone assay diagnosis guideline ficantly warfarin transplant
8 Most Recent Publications
|
International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
(Article)
Cavo, M. Rajkumar, S.V. Sonneveld, P. Boccadoro, M. Anderson, K.C. Richardson, P.G. Bensinger, W. Johnsen, H.E. Kroeger, N. Gahrton, G. Bergsagel, P.L. Vesole, D.H. Palumbo, A. Einsele, H. Jagannath, S. Niesvizky, R. Durie, B.G.M. Miguel, J.S. Lonial, S. Moreau, P. Orlowski, R.Z. Bladé, J. Sezer, O. Ludwig, H. Dimopoulos, M.A. Attal, M. |
2011-06-09
|
|
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: Consensus statement
(Article)
Dimopoulos, M.A. Palumbo, A. Ludwig, H. Mellqvist, U.H. Morgan, G. San Miguel, J-F. Zweegman, S. Sonneveld, P. Attal, M. Beksaç, M. Davies, F. Delforge, M. Einsele, H. Hajek, R. Harousseau, J-L. Da Costa, F.L. |
2011-05-01
|
|
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
(Article)
Giralt, S. Stadtmauer, E.A. Merlini, G. San Miguel, J. Ludwig, H. Hajek, R. Jagannath, S. Blade, J. Lonial, S. Dimopoulos, M.A. Einsele, H. Barlogie, B. Harousseau, J-L. Anderson, K.C. Gertz, M. Attal, M. Tosi, P. Sonneveld, P. Boccadoro, M. Morgan, G. Sezer, O. Mateos, M.V. Cavo, M. Palumbo, A. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Powles, R. Richardson, P.G. Niesvizky, R. Rajkumar, S.V. Durie, B.G.M. Bensinger, W. Comenzo, R.L. Kumar, S. Munshi, N.C. Dispenzieri, A. Kyle, R. |
2009-06-26
|
|
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(Article)
Palumbo, A. Sezer, O. Kumar, S. Hajek, R. Giralt, S. Bringhen, S. Anderson, K.C. Richardson, P.G. Cavo, M. Davies, F. Bladé, J. Einsele, H. Kyle, R. Dimopoulos, M.A. Spencer, A. Dispenzieri, A. Reiman, T. Shimizu, K. Lee, J.H. Attal, M. Boccadoro, M. Mateos, M.V. Chen, W. Miguel, J.S. Ludwig, H. Joshua, D. Chim, J. Hungria, V. Turesson, I. Durie, B.G.M. Lonial, S. Orlowski, R.Z. Moreau, P. Niesvizky, R. Morgan, G. Comenzo, R.L. Sonneveld, P. |
2009-06-08
|
|
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
(Article)
Palumbo, A. Dimopoulos, M.A. Miguel, J.S. Harousseau, J-L. Attal, M. Hussein, M. Knop, S. Ludwig, H. Lilienfeld-Toal, M. Von Sonneveld, P. |
2009-03-01
|
|
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(Article)
Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S. |
2009-01-01
|
|
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: An analysis of 10 549 patients from the International Myeloma Working Group
(Article)
Ludwig, H. Durie, B.G.M. Westin, J. Harousseau, J-L. Beksac, M. Boccadoro, M. Palumbo, A. Barlogie, B. Shustik, C. Cavo, M. Greipp, P. Joshua, D. Bolejack, V. Attal, M. Sonneveld, P. Crowley, J. Turesson, I. Kyle, R. Bladé, J. Fonseca, R. Dimopoulos, M.A. Shimizu, K. Miguel, J.S. |
2008-04-15
|
|
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
(Article)
Palumbo, A. Rajkumar, S.V. Attal, M. Belch, A. Knop, S. Joshua, D. Sezer, O. Ludwig, H. Vesole, D. Bladé, J. Kyle, R. Westin, J. Dimopoulos, M.A. Weber, D. Bringhen, S. Niesvizky, R. Waage, A. Lilienfeld-Toal, M. Von Lonial, S. Morgan, G. Orlowski, R.Z. Shimizu, K. Anderson, K.C. Richardson, P.G. Boccadoro, M. Durie, B.G.M. Sonneveld, P. Hussein, M. San Miguel, J-F. Barlogie, B. Harousseau, J-L. Zonder, J.A. Cavo, M. Zangari, M. |
2008-02-01
|
